Leading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise.
2014 Q1: GSK Post N892millionPre-tax Profits Continuing In Its Modest Growth
Nairametrics
Nairametrics is Nigeria's top business news and financial analysis website. We focus on providing resources that help small businesses and retail investors make better investing decisions. Nairametrics is updated daily by a team of professionals. Post updated as "Nairametrics" are published by our Editorial Board.
